Sherry Wang

1.4k total citations
15 papers, 807 citations indexed

About

Sherry Wang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Sherry Wang has authored 15 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Sherry Wang's work include Lung Cancer Treatments and Mutations (5 papers), Pesticide Residue Analysis and Safety (3 papers) and Hormonal and reproductive studies (2 papers). Sherry Wang is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Pesticide Residue Analysis and Safety (3 papers) and Hormonal and reproductive studies (2 papers). Sherry Wang collaborates with scholars based in United States, Australia and Canada. Sherry Wang's co-authors include Eric Yang, Matthew J. Cyronak, Lucy Shapiro, Rasmus Bugge Jensen, Keith D. Wilner, Sai‐Hong Ignatius Ou, Hermes Licea‐Perez, Matthew Szapacs, Jeffrey W. Clark and Mark A. Socinski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Nature Reviews Molecular Cell Biology.

In The Last Decade

Sherry Wang

13 papers receiving 784 citations

Peers

Sherry Wang
Patrick Bennett United States
Zengru Wu United States
Chinmoy Ghosh India
Gwyn A. Lord United Kingdom
Keith Waddell United Kingdom
Xianfu Gao China
J. De Graeve Belgium
Hyuk Nam Kwon South Korea
Fabio Garofolo United States
Zhuoling An China
Patrick Bennett United States
Sherry Wang
Citations per year, relative to Sherry Wang Sherry Wang (= 1×) peers Patrick Bennett

Countries citing papers authored by Sherry Wang

Since Specialization
Citations

This map shows the geographic impact of Sherry Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Wang more than expected).

Fields of papers citing papers by Sherry Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherry Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Wang. The network helps show where Sherry Wang may publish in the future.

Co-authorship network of co-authors of Sherry Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Sherry Wang. A scholar is included among the top collaborators of Sherry Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry Wang. Sherry Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Jayaram, Anuradha, Nicholas A. Zorko, Kevin Zarrabi, et al.. (2026). A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer. Cancer Chemotherapy and Pharmacology. 96(1). 5–5.
2.
Shen, Fei, Krista Menard, Shaozhou K. Tian, et al.. (2025). Human Kallikrein 2: A Novel Lineage-Specific Surface Target in Prostate Cancer. Clinical Cancer Research. 31(21). 4543–4556.
3.
Ng, Terry L., David Chun Cheong Tsui, Sherry Wang, et al.. (2022). Association of anticoagulant use with clinical outcomes from crizotinib in ALK‐ and ROS1‐rearranged advanced non‐small cell lung cancers: A retrospective analysis of PROFILE 1001. Cancer Medicine. 11(23). 4422–4429. 6 indexed citations
4.
Camidge, D. Ross, Gregory A. Otterson, Jeffrey W. Clark, et al.. (2021). Crizotinib in Patients With MET-Amplified NSCLC. Journal of Thoracic Oncology. 16(6). 1017–1029. 109 indexed citations
5.
Solomon, Benjamin, Elizabeth E. Kim, Yiyun Tang, et al.. (2020). Ophthalmological assessment of crizotinib in advanced non-small-cell lung cancer. Lung Cancer. 145. 167–172. 5 indexed citations
6.
Drilon, A., Sai‐Hong Ignatius Ou, Jeffrey W. Clark, et al.. (2017). MA16.09 Antitumor Activity and Safety of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S438–S439. 12 indexed citations
7.
Drilon, Alexander, D. Ross Camidge, Sai‐Hong Ignatius Ou, et al.. (2016). Efficacy and safety of crizotinib in patients (pts) with advanced MET exon 14-altered non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 34(15_suppl). 108–108. 88 indexed citations
8.
Licea‐Perez, Hermes, et al.. (2015). Camphanic Acid Chloride: A Powerful Derivatization Reagent for Stereoisomeric Separation and its DMPK Applications. Bioanalysis. 7(23). 3005–3017. 11 indexed citations
9.
Kirby, R. Lee, et al.. (2015). Proportion of Wheelchair Users Who Receive Wheelchair Skills Training During an Admission to a Canadian Rehabilitation Center. Topics in Geriatric Rehabilitation. 31(1). 58–66. 28 indexed citations
10.
11.
Wang, Sherry, Matthew J. Cyronak, & Eric Yang. (2006). Does a stable isotopically labeled internal standard always correct analyte response?. Journal of Pharmaceutical and Biomedical Analysis. 43(2). 701–707. 323 indexed citations
12.
13.
Yang, Eric, et al.. (2004). Stereoselective analysis of carvedilol in human plasma using HPLC/MS/MS after chiral derivatization. Journal of Pharmaceutical and Biomedical Analysis. 36(3). 609–615. 69 indexed citations
14.
Wang, Sherry & Lucy Shapiro. (2004). The topoisomerase IV ParC subunit colocalizes with the Caulobacter replisome and is required for polar localization of replication origins. Proceedings of the National Academy of Sciences. 101(25). 9251–9256. 31 indexed citations
15.
Jensen, Rasmus Bugge, Sherry Wang, & Lucy Shapiro. (2002). Dynamic localization of proteins and DNA during a bacterial cell cycle. Nature Reviews Molecular Cell Biology. 3(3). 167–176. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Bennett Breakdown of academic impact, for papers by Zengru Wu Breakdown of academic impact, for papers by Chinmoy Ghosh Breakdown of academic impact, for papers by Gwyn A. Lord Breakdown of academic impact, for papers by Keith Waddell Breakdown of academic impact, for papers by Xianfu Gao Breakdown of academic impact, for papers by J. De Graeve Breakdown of academic impact, for papers by Hyuk Nam Kwon Breakdown of academic impact, for papers by Fabio Garofolo Breakdown of academic impact, for papers by Zhuoling An
Rankless by CCL
2026